Skip to search.
 STI Down 0.83%

Becton, Dickinson and Company (BDX)

-NYSE
161.26 Down 0.67(0.41%) 30 Apr 04:00 SGT
|After Hours : 161.26 0.00 (0.00%) 30 Apr 04:47 SGT
Prev Close:161.93
Open:161.01
Bid:161.27 x 400
Ask:161.30 x 100
1y Target Est:166.88
Beta:1.00829
Next Earnings Date: 5-May-16BDX Earnings announcement
Day's Range:159.81 - 161.32
52wk Range:128.87 - 162.98
Volume:1,344,251
Avg Vol (3m):1,067,070
Market Cap:34.16B
P/E (ttm):49.77
EPS (ttm):3.24
Div & Yield:2.64 (1.65%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BDXDown 0.41%34.16B
BAXDown 0.09%24.33B
ABTDown 3.76%57.31B

Key Statistics

Forward P/E (1 yr):17.12
P/S (ttm):3.06
Ex-Dividend Date:08-Mar-16

Analysts

Annual EPS Est (Sep-16) :8.45
Quarterly EPS Est (Mar-16) :2.02
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.43

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company’s BD Medical segment offers syringes and pen needles for diabetes; needles, syringes, and intravenous cat... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback